Key Metrics 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
JK Pharmachem Ltd (JKPHARMA)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 500218 NSE: JKPHARMA Pharmaceuticals & Drugs | Small Cap | JK Pharmachem Share Price
BSE Share Price
Not Listed
Not Listed
JK Pharmachem Ltd (JKPHARMA)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 500218 NSE: JKPHARMA Pharmaceuticals & Drugs | Small Cap | JK Pharmachem Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹11 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
54.2
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-86.37%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
%
Pledged shares (%) of Promoter's holding (%)
%
Reserves
-
Equity
₹62.7 Cr.
Face Value
₹10
All Time Low / High
₹1.10 / 26.00
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
JK Pharmachem Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation ⓘ
| Sep'96 | Sep'97 | Sep'98 | Sep'99 | Sep'00 | Sep'01 | Sep'02 | Sep'03 | Sep'04 | Sep'05 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 0% | 0% | 2.8% | -1.2% | -5.5% | -2.4% | 10.5% | 0.9% | -16.3% | -4% | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 0 | 0 | 71.8 | 68.5 | 72.9 | 70.3 | 95.3 | 78.4 | 38.4 | 5.2 | 0 |
| Sales YoY Gr. | - | NA | NA | -4.5% | 6.3% | -3.5% | 35.5% | -17.8% | -51% | -86.4% | - |
| Adj EPS ⓘ | 0 | 0 | -3.6 | -4.8 | -3.7 | -2.3 | 0.7 | -1.1 | -4.9 | -1.7 | -1.3 |
| YoY Gr. | - | NA | NA | NA | NA | NA | NA | -271.2% | NA | NA | - |
| BVPS (₹) ⓘ | 0 | 0 | 9.3 | 4.6 | 2.9 | 0.8 | 2.7 | 1.9 | -4 | -6 | -6.5 |
| Adj Net Profit ⓘ | 0 | 0 | -14.8 | -19.9 | -23 | -14.2 | 4.2 | -7.1 | -30.5 | -10.7 | -8 |
| Cash Flow from Ops. ⓘ | 0 | 0 | 8.6 | 8 | 6.4 | 8.2 | 13.1 | 8.2 | 2.4 | 3.5 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | 16 | 17.4 | 16.3 | 13.1 | 7.9 | 12.3 | 44.1 | 31.4 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | -41% | -62% | -86.4% | ||||
| Adj EPS ⓘ | NA | NA | -237.4% | NA | ||||
| BVPSⓘ | NA | -215.8% | -230.6% | NA | ||||
| Share Price | - | - | - | - | ||||
Key Financial Parameters ⓘ
| Sep'96 | Sep'97 | Sep'98 | Sep'99 | Sep'00 | Sep'01 | Sep'02 | Sep'03 | Sep'04 | Sep'05 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 0 | 0 | -33.5 | -50.9 | -52.8 | -31 | 9.5 | -15.2 | -121.5 | -7629.2 | 21 |
| Op. Profit Mgn % ⓘ | 0 | 0 | 16.6 | 9.7 | 0.4 | 7.5 | 21.9 | 11.5 | -37.2 | -81.6 | -2583.3 |
| Net Profit Mgn % ⓘ | 0 | 0 | -20.6 | -29 | -31.6 | -20.2 | 4.4 | -9.1 | -79.4 | -204.4 | -13685.1 |
| Debt to Equity ⓘ | 0 | 0 | 3.6 | 4.9 | 2.1 | 3 | 2.1 | 2.3 | 17.7 | -18.2 | - |
| Working Cap Days ⓘ | 0 | 0 | 0 | 136 | 121 | 113 | 90 | 123 | 196 | 684 | 0 |
| Cash Conv. Cycle ⓘ | 0 | 0 | 0 | 52 | 45 | 29 | 29 | 73 | 123 | -121 | 0 |
Valuation of JK Pharmachem - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
No Data To Display
Promoter's Holding & Share Pledging
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
JK Pharmachem Ltd FAQs
The current trading price of JK Pharmachem on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of JK Pharmachem stood at ₹11.22 Cr
The latest P/E ratio of JK Pharmachem as of 31-Dec-1969 is 0.00.
The latest P/B ratio of JK Pharmachem as of 31-Dec-1969 is -0.28.
The 52-week high of JK Pharmachem is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of JK Pharmachem is ₹0.06 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that JK Pharmachem Ltd is a average quality company.
No data found
No data found
About JK Pharmachem Ltd
JK Pharmachem was incorporated on March 16, 1990. The company produces penicillin-G at its Cuddalore plant in Tamil Nadu with an installed capacity of 1,250 MMU.
The company has its own research and development facility for bio-technology research. With its net worth fully eroded, the company is under receivership now. It has been suspended from BSE on account of non compliance with listing agreement clauses.
The registered office of the company is located at A-7 SIPCOT Industrial Complex, South Arcot, Vallalar district, Cuddalore, Tamil Nadu-607005.
Business area of the company
The company is engaged in the manufacture of drugs and pharmaceuticals.
You have 44 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
